Key Drivers
- Cash conversion
- Thin margins
- Weak liquidity
AIAI Summary
CAH should be viewed less as a low-margin distributor and more as a cash-generating healthcare platform with improving specialty/at-home growth and strong capital returns, but the recent EPS beat was helped by a tariff refund and the thin-margin, working-capital-heavy model means the upside depends on sustained execution rather than one-off boosts.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash conversion
- •Thin margins
- •Weak liquidity
CAH generates strong cash flow and asset efficiency, but its razor-thin margins, negative book equity, and tight liquidity make the stock look expensive and financially fragile.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •240 resistance
- •Rebound consolidation
CAH has drifted higher over the last month with a clear $227-$230 support base, but the rally remains capped near $239-$240 and still looks more like consolidation than a breakout.
Pushed to a short-term high on 2026-08-11, then quickly dropped into 2026-08-13 before rebounding on 2026-08-14
Sentiment & News
Key News Insights:
- •EPS growth
- •Cash strength
- •Outlook boost
Cardinal Health delivered a strong Q4/FY2026 earnings beat with robust cash flow and buybacks, and management's FY2027 outlook for 13%–15% EPS growth has fueled a sharp stock rally despite some revenue caution.
The upbeat earnings, cash generation, and FY2027 guidance are likely to support continued investor confidence and valuation upside for CAH
Similar Companies in Healthcare
Other companies in the same sector with AI ratings